An iPSC-derived small intestine-on-chip with self-organizing epithelial, mesenchymal, and neural cells.

CP: Stem cell research differentiation medium enteric neuron gut-on-chip human induced pluripotent stem cell intestinal epithelial barrier intestine-on-chip mesenchyme organ-on-chip small intestine

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
20 Jun 2024
Historique:
received: 23 02 2024
revised: 10 04 2024
accepted: 02 05 2024
medline: 22 6 2024
pubmed: 22 6 2024
entrez: 22 6 2024
Statut: aheadofprint

Résumé

Human induced pluripotent stem cell (hiPSC)-derived intestinal organoids are valuable tools for researching developmental biology and personalized therapies, but their closed topology and relative immature state limit applications. Here, we use organ-on-chip technology to develop a hiPSC-derived intestinal barrier with apical and basolateral access in a more physiological in vitro microenvironment. To replicate growth factor gradients along the crypt-villus axis, we locally expose the cells to expansion and differentiation media. In these conditions, intestinal epithelial cells self-organize into villus-like folds with physiological barrier integrity, and myofibroblasts and neurons emerge and form a subepithelial tissue in the bottom channel. The growth factor gradients efficiently balance dividing and mature cell types and induce an intestinal epithelial composition, including absorptive and secretory lineages, resembling the composition of the human small intestine. This well-characterized hiPSC-derived intestine-on-chip system can facilitate personalized studies on physiological processes and therapy development in the human small intestine.

Identifiants

pubmed: 38907996
pii: S2211-1247(24)00575-8
doi: 10.1016/j.celrep.2024.114247
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114247

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no conflicts of interest.

Auteurs

Renée Moerkens (R)

Department of Genetics, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, the Netherlands.

Joram Mooiweer (J)

Department of Genetics, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, the Netherlands.

Aarón D Ramírez-Sánchez (AD)

Department of Genetics, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, the Netherlands.

Roy Oelen (R)

Department of Genetics, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, the Netherlands; Oncode Institute, 3521 AL Utrecht, the Netherlands.

Lude Franke (L)

Department of Genetics, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, the Netherlands; Oncode Institute, 3521 AL Utrecht, the Netherlands.

Cisca Wijmenga (C)

Department of Genetics, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, the Netherlands.

Robert J Barrett (RJ)

Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA; F. Widjaja Foundation Inflammatory Bowel Disease Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Iris H Jonkers (IH)

Department of Genetics, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, the Netherlands.

Sebo Withoff (S)

Department of Genetics, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, the Netherlands. Electronic address: s.withoff@umcg.nl.

Classifications MeSH